Orthopediatrics (KIDS) Depreciation & Amortization (CF) (2016 - 2026)
Orthopediatrics' (KIDS) quarterly Depreciation & Amortization (CF) came in at $5.7 million in Q1 2026, up 13.33% year-on-year from $5.0 million in Q1 2025, and up 2.12% on a QoQ basis from $5.6 million in Q4 2025.
Orthopediatrics (KIDS) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends
Orthopediatrics (KIDS) has 11 years of Depreciation & Amortization (CF) data on file, last reported at $5.7 million in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 13.33% year-over-year to $5.7 million in Q1 2026; TTM through Mar 2026 was $21.8 million, a 14.09% increase from a year earlier, with the FY2025 full-year figure at $21.1 million, up 10.69% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $5.7 million, up from $5.6 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for KIDS reached as high as $5.7 million in Q1 2026 and fell as low as $3.0 million in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $4.5 million across 5 years, with a median of $4.8 million in 2024.
- Across the five-year window, Depreciation & Amortization (CF) soared 47.36% in 2023 and declined 23.02% in 2024, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $3.5 million in 2022, then surged by 47.36% to $5.2 million in 2023, then fell by 23.02% to $4.0 million in 2024, then soared by 40.3% to $5.6 million in 2025, then increased by 2.12% to $5.7 million in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $5.7 million in Q1 2026, $5.6 million in Q4 2025, and $5.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | 67.10 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 78.00 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 310.25 Mn |
| 10 | Orthopediatrics | 468.49 Mn | 454.25 Mn | 43.39 Mn | 5.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.72 Mn |
| Mar 31, 2026 | 5.72 Mn |
| Dec 31, 2025 | 5.60 Mn |
| Dec 31, 2025 | 5.60 Mn |
| Sep 30, 2025 | 5.30 Mn |
| Sep 30, 2025 | 5.30 Mn |
| Jun 30, 2025 | 5.17 Mn |
| Jun 30, 2025 | 5.17 Mn |
| Mar 31, 2025 | 5.05 Mn |
| Mar 31, 2025 | 5.05 Mn |
| Dec 31, 2024 | 3.99 Mn |
| Dec 31, 2024 | 3.99 Mn |
| Sep 30, 2024 | 5.28 Mn |
| Sep 30, 2024 | 5.28 Mn |
| Jun 30, 2024 | 4.78 Mn |
| Jun 30, 2024 | 4.78 Mn |
| Mar 31, 2024 | 5.03 Mn |
| Mar 31, 2024 | 5.03 Mn |
| Dec 31, 2023 | 5.19 Mn |
| Dec 31, 2023 | 5.19 Mn |